Table 1

Baseline characteristics for trial participants

CharacteristicIntervention Active controlUsual care P value**
N = 95N = 62N = 71*
Sex, n (% female)58 (61)29 (47)40 (56)0.21
Age (year), mean (SD)57.0 (10.5)59.2 (8.5)63.4 (11.3)<0.001
Obese (BMI >30 kg/m2), n (%)71 (76)44 (72)47 (68)0.49
Education less than high school, n (%)11 (12)10 (16)14 (20)0.60
Employed, n (%)48 (52)31 (51)25 (36)0.27
White, n (%)81 (87)49 (80)66 (96)0.07
Income, n (%)
 <$40,00028 (30)16 (26)29 (46)0.24
 $40,000–$80,00023 (25)16 (26)15 (24)
 ≥$80,00026 (28)13 (21)16 (25)
 Refused to answer3 (3)8 (13)3 (5)
Smoking, n (%)23 (25)15 (25)13 (18)0.42
Alcohol use, n (%)70 (75)41 (67)42 (59)0.09
Psychoactive medications***, n (%)46 (48)27 (44)0.55
PHQ, mean (SD)14.5 (3.8)14.6 (3.5)14.2 (3.4)0.79
A1C (%), mean (SD)7.5 (1.8)7.8 (1.7)0.18
A1C (mmol/mol), mean (SD)58 (19.7)62 (18.6)0.18
SBP (mmHg), mean (SD)126 (15.5)124 (16.5)0.29
LDL-cholesterol (mmol/L), mean (SD)2.2 (0.9)2.1 (0.8)0.48
  • *Drawn from similar patients in ABCD cohort; medication and laboratory data were not available.

  • **From t test for continuous data or χ2 for categorical data.

  • ***Antidepressants, anxiolytics, mood stabilizers, and/or antipsychotics.